Admission Date:  [**2120-9-21**]              Discharge Date:   [**2120-9-25**]  Date of Birth:  [**2043-6-19**]             Sex:   M  Service: MEDICINE  Allergies: Penicillins / Sulfa (Sulfonamides) / Iodine  Attending:[**First Name3 (LF) 2297**] Chief Complaint: Acute drop in hct  Major Surgical or Invasive Procedure: None  History of Present Illness: 77 year-old man with a history of T3N1 poorly differentiated esphageal cancer diagnosed earlier this year, diabetes type II and asthma, hx of two spinal surgeries after trauma who was admitted to the [**Hospital Unit Name 153**] for acute drop in Hct.
His post-op course was complicated by desaturations requiring intubation with extubation on [**9-3**], hct drop responsive to transfusion, pneumonia with GNR-serratia and GPC not identified, frank aspiration necessitating feeding tube placement by IR and poor urine output.
On arrival to the ED that day, he was found to be desaturating on 6L NC so he was taken to the OR by anesthesia due to his recent cervical surgeries.
On arrival to the [**Name (NI) **], pt was asymptomatic and HD stable.
He received one unit of NS and 2U PRBCs.
A chest and abd CTA was done given concern for perforation following PEG placement but was negative for any bleeding, perforation or dissection.
Past Medical History: PAST MEDICAL HISTORY:  Significant for diabetes type 2, mild asthma, [**Doctor Last Name 3271**]-[**Doctor Last Name **] virus, lower extremity edema, T3N1 poorly differentiated esophageal cancer s/p palliative chemotherapy and XRT.
.. PAST SURGICAL HISTORY:  Status post inguinal hernia repair in [**2082**], and he is status post exploratory laparotomy in [**2098**] for abdominal pain, at which time they performed an incidental cholecystectomy and appendectomy.
Anterior partial vertebrectomy of C5, C6, C7.
Physical Exam: Exam: T 96.1 BP 118/72 P 86 R 20 O2 99% 5L Gen: NAD, AO x 3 HEENT: PERRL, mmm, large nontender mass at back of neck CV: rrr, s1 s2 Chest: ctab Abd: PEG tube in place, clean dressing; +BS, soft, NT/ND Ext: trace edema b/l, 1+ DP   Pertinent Results: [**2120-9-21**] 08:22PM   LACTATE-1.6 [**2120-9-21**] 02:15PM   GLUCOSE-144* UREA N-40* CREAT-1.1 SODIUM-137 POTASSIUM-3.3 CHLORIDE-100 TOTAL CO2-25 ANION GAP-15 [**2120-9-21**] 02:15PM   WBC-7.0 RBC-2.07* HGB-6.5*# HCT-19.5* MCV-95 MCH-31.3 MCHC-33.1 RDW-17.6* [**2120-9-21**] 02:15PM   NEUTS-83.0* BANDS-0 LYMPHS-11.1* MONOS-4.7 EOS-0.9 BASOS-0.2 [**2120-9-21**] 02:15PM   HYPOCHROM-NORMAL ANISOCYT-3+ POIKILOCY-OCCASIONAL MACROCYT-2+ MICROCYT-2+ POLYCHROM-2+ OVALOCYT-OCCASIONAL STIPPLED-OCCASIONAL [**2120-9-21**] 02:15PM   PLT SMR-NORMAL PLT COUNT-323 [**2120-9-21**] 02:15PM   PT-13.7* PTT-37.2* INR(PT)-1.3  [**2120-9-24**] B/L UE U/S IMPRESSION:  No DVT within the left or right upper extremity.
Brief Hospital Course: A/P: 77M with hx of DM, asthma, cervical spine fractures s/p fusion and repair, aspiration pneumonia s/p PEG placement, esophageal cancer presents with acute on chronic anemia .
On day one and two of admission the pt received three units of prbcs with appropriate bumps in his hematocrit.
The risks and benefits of restarting lovenox were discussed amongst the team members.
Given his risk for re-bleed, it was decided to hold his lovenox on discharge.
He is followed by an oncologist in NH and is S/P XRT and chemotherapy with Cisplatin.
4) DM: The pt was maintained on an RISS throughout admission.
5) Asthma: The pt was maintained on albuterol/atrovent nebs prn throughout his admission.
6) hx of tachycardia/MAT: Ther pt was continued on a CCB for HR control.
7) Stage 3 sacral decub: The pt was continued on vitamin C, zinc, and daily wound care and placed on an air mattress.
8) FEN: The pt is s/p PEG tube placement.
9) Ppx: The pt was placed on pneumoboots, a PPI, bowel regimen, and aspiration precautions throughout the admission.
Enoxaparin 80 mg/0.8 mL Syringe Sig: One (1) injection Subcutaneous Q12H (every 12 hours).
Ipratropium Bromide 18 mcg/Actuation Aerosol Sig: Two (2) Puff Inhalation QID (4 times a day).
Albuterol 90 mcg/Actuation Aerosol Sig: 1-2 Puffs Inhalation Q6H (every 6 hours).
Zinc Sulfate 220 mg Capsule Sig: One (1) Capsule PO DAILY (Daily).
Ascorbic Acid 500 mg Tablet Sig: One (1) Tablet PO BID (2 times a day).
Diltiazem HCl 60 mg Tablet Sig: One (1) Tablet PO QID (4 times a day).
7. insulin sliding scale 8.
Potassium Chloride 20 mEq Packet Sig: One (1) packet PO once a day.
Vancomycin in Dextrose 1 g/200 mL Piggyback Sig: One (1) Intravenous  Q 12H (Every 12 Hours) for 5 days.
Lansoprazole 30 mg Capsule, Delayed Release(E.C.)
Heparin Lock Flush (Porcine) 100 unit/mL Syringe Sig: Two (2) ML Intravenous  DAILY (Daily) as needed.
Discharge Disposition: Extended Care  Facility: [**Hospital6 979**] - [**Location (un) 246**]  Discharge Diagnosis: Primary: Neck hematoma  secondary: esophageal CA MAT DM sacral decubital ulcer   Discharge Condition: Stable   Discharge Instructions: To pt: Please take all medication as prescribed.
- Continue tube feeds.
- Continue PT - Oxygen as needed to keep sts>94% - Continue zinc and vitamin C to help wound healing of sacral decubital ulcer.
- Please continue air mattress and frequent repositioning.
- Please monitor fingersticks and use humalog insulin sliding scale.
